GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (TSE:4519) » Definitions » Cyclically Adjusted FCF per Share

Chugai Pharmaceutical Co (TSE:4519) Cyclically Adjusted FCF per Share : 円101.39 (As of Mar. 2025)


View and export this data going back to 1956. Start your Free Trial

What is Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Chugai Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2025 was 円26.800. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is 円101.39 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Chugai Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 27.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 28.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 25.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Chugai Pharmaceutical Co was 28.90% per year. The lowest was 13.60% per year. And the median was 21.30% per year.

As of today (2025-05-28), Chugai Pharmaceutical Co's current stock price is 円7495.00. Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was 円101.39. Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 73.92.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Chugai Pharmaceutical Co was 197.55. The lowest was 53.01. And the median was 79.12.


Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.37 46.75 55.23 74.52 100.14

Chugai Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.55 82.27 89.83 100.14 101.39

Competitive Comparison of Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chugai Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=26.8/111.1000*111.1000
=26.800

Current CPI (Mar. 2025) = 111.1000.

Chugai Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 4.082 98.400 4.609
201509 7.031 98.500 7.930
201512 -4.009 98.100 -4.540
201603 1.502 97.900 1.705
201606 -4.108 98.100 -4.652
201609 9.539 98.000 10.814
201612 -5.491 98.400 -6.200
201703 13.034 98.100 14.761
201706 3.616 98.500 4.079
201709 1.659 98.800 1.866
201712 20.105 99.400 22.471
201803 24.005 99.200 26.885
201806 5.160 99.200 5.779
201809 6.402 99.900 7.120
201812 -10.369 99.700 -11.555
201903 13.326 99.700 14.850
201906 16.963 99.800 18.884
201909 30.764 100.100 34.145
201912 27.421 100.500 30.313
202003 -4.442 100.300 -4.920
202006 11.954 99.900 13.294
202009 42.580 99.900 47.354
202012 37.209 99.300 41.631
202103 8.904 99.900 9.902
202106 29.472 99.500 32.908
202109 34.350 100.100 38.125
202112 52.959 100.100 58.779
202203 21.731 101.100 23.880
202206 96.837 101.800 105.684
202209 9.889 103.100 10.656
202212 -23.690 104.100 -25.283
202303 61.116 104.400 65.038
202306 63.839 105.200 67.419
202309 13.325 106.200 13.940
202312 64.411 106.800 67.004
202403 53.707 107.200 55.661
202406 28.831 108.200 29.604
202409 63.772 108.900 65.060
202412 91.737 110.700 92.068
202503 26.800 111.100 26.800

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Chugai Pharmaceutical Co  (TSE:4519) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=7495.00/101.39
=73.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Chugai Pharmaceutical Co was 197.55. The lowest was 53.01. And the median was 79.12.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and Actemra for treating rheumatoid arthritis and covid patients.

Chugai Pharmaceutical Co Headlines

No Headlines